-
121
Treatment of Androgenetic Alopecia: Current Guidance and Unmet Needs
Published 2023-05-01“…Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, FL, USA; 2Charles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, FL, USA; 3Forefront Dermatology, Vienna, VA, USA; 4Issa Research and Consulting, LLC, Springfield, VA, USACorrespondence: Joaquin J Jimenez, Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, FL, USA, Tel +1 305-243-6586, Email j.jimenez@med.miami.eduAbstract: Androgenetic alopecia (AGA) is the most common cause of hair loss in men and women. …”
Get full text
Article -
122
The role of G-CSF neuroprotective effects in neonatal hypoxic-ischemic encephalopathy (HIE): current status
Published 2021-02-01Get full text
Article -
123
Chitin protects the gut epithelial barrier in a protochordate model of DSS-induced colitis
Published 2018-01-01Get full text
Article -
124
-
125
-
126
-
127
-
128
-
129
-
130
Sarcopenic obesity and cognitive performance
Published 2018-06-01“…Magdalena I Tolea,1 Stephanie Chrisphonte,1 James E Galvin1,2 1Charles E. Schmidt College of Medicine, Department of Integrated Medical Sciences, Comprehensive Center for Brain Health, Florida Atlantic University, Boca Raton, FL, USA; 2Christine E. …”
Get full text
Article -
131
Use of immediate-release opioids as supplemental analgesia during management of moderate-to-severe chronic pain with buprenorphine transdermal system
Published 2017-05-01“…Sanford Silverman,1,2 Robert B Raffa,3,4 Marc J Cataldo,5 Monica Kwarcinski,5 Steven R Ripa5 1Comprehensive Pain Medicine, Pompano Beach, 2Department of Integrated Medical Sciences, Charles E Schmidt College of Medicine, Florida Atlantic University, Boca Raton, FL, 3Department of Pharmaceutical Sciences, School of Pharmacy, Temple University, Philadelphia, PA, 4Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, AZ, 5Purdue Pharma LP, Stamford, CT, US Background: The buprenorphine transdermal system (BTDS) is approved in the US for the management of chronic pain. …”
Get full text
Article -
132
AdipoRon Treatment Induces a Dose-Dependent Response in Adult Hippocampal Neurogenesis
Published 2021-02-01Get full text
Article -
133
Inflammatory Regulation of CNS Barriers After Traumatic Brain Injury: A Tale Directed by Interleukin-1
Published 2021-05-01Get full text
Article -
134
Intravenous lidocaine in spine surgery: A meta-analysis of randomized controlled trials
Published 2021-09-01Get full text
Article -
135
-
136
24-Month Outcomes of Ahmed ClearPath® Glaucoma Drainage Device for Refractory Glaucoma
Published 2022-07-01“…Syril Dorairaj,1 Leticia A Checo,1 Isabella V Wagner,1 Richard D Ten Hulzen,1 Abhimanyu S Ahuja2 1Department of Ophthalmology, Mayo Clinic, Jacksonville, FL, USA; 2Charles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, FL, USACorrespondence: Syril Dorairaj, Department of Ophthalmology, Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL, USA, Tel +1 904-953-2377, Fax +1 904-953-7040, Email dorairaj.syril@mayo.eduPurpose: To describe the safety and efficacy of the Ahmed ClearPath® (ACP) 250 mm2 glaucoma drainage device (GDD) in the treatment of refractory primary open-angle glaucoma (POAG).Patients and methods: This was a retrospective, noncomparative, single-surgeon, interventional case series of adult patients with medically ± surgically refractory POAG undergoing ACP implantation. …”
Get full text
Article -
137
Access to Total Knee Arthroplasty for Military Insured Patients
Published 2023-06-01Get full text
Article -
138
-
139
-
140